About Shawn Tomasello
Form D filings for Centrexion Therapeutics from 2018 to 2024 list Shawn Tomasello as director.
Shawn Tomasello first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Shawn Tomasello in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shawn Tomasello works with at each company, as listed on that company's latest Form D.
Centrexion Therapeutics Corp · Form D, Jan 8, 2024
MW
Michael Ward
Chief Financial Officer, Treasurer, and Secretary
JD
James Campbell, M.D.
Executive officer and director
SD
Sol Barer, Ph.D.
Director
CH
Colin Hill
Director
RS
Randall Stevens
Executive officer
JS
Joseph Swedish
Director
JK
Jeffrey Kindler
Executive officer and director
JD
J.c. Lopez, M.D.
Director